People with MS visited doctors, were hospitalized, and used emergency care more than other people decades before their ...

Sanofi’s SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration Designation earned for a one-time intravitreal gene therapy designed to inhibit ...

US FDA grants fast track designation to Sanofi’s SAR446597 to treat geographic atrophy due to age-related macular degeneration: Paris Thursday, July 17, 2025, 10:00 Hrs [IST] Th ...

Multiple sclerosis, the prototype of demyelinating disease in man, is a relapsing-remitting or progressively disabling disease of unknown cause. The first pathological descriptions of the disease ...

Some vitamins and herbal supplements may help to relieve MS symptoms, but others are ineffective and might even be harmful. Learn which is which.

Antonella Favit-Van Pelt, MD, PhD, discusses the use of neuromodulation and neuroplasticity for addressing gait deficits in patients with multiple sclerosis.

Paris: Sanofi has received fast track designation from the US Food and Drug Administration (FDA) for SAR446597, a one-time ...